These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 16948531)
1. Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system. Balada-Llasat JM; Mecsas J PLoS Pathog; 2006 Sep; 2(9):e86. PubMed ID: 16948531 [TBL] [Abstract][Full Text] [Related]
2. Oral inoculation with Type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia. Balada-Llasat JM; Panilaitis B; Kaplan D; Mecsas J Vaccine; 2007 Feb; 25(8):1526-33. PubMed ID: 17194509 [TBL] [Abstract][Full Text] [Related]
3. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes. Crimmins GT; Mohammadi S; Green ER; Bergman MA; Isberg RR; Mecsas J PLoS Pathog; 2012; 8(8):e1002828. PubMed ID: 22876175 [TBL] [Abstract][Full Text] [Related]
4. The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection. Durand EA; Maldonado-Arocho FJ; Castillo C; Walsh RL; Mecsas J Cell Microbiol; 2010 Aug; 12(8):1064-82. PubMed ID: 20148898 [TBL] [Abstract][Full Text] [Related]
5. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches. Logsdon LK; Mecsas J Infect Immun; 2006 Mar; 74(3):1516-27. PubMed ID: 16495522 [TBL] [Abstract][Full Text] [Related]
6. Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Autenrieth IB; Kempf V; Sprinz T; Preger S; Schnell A Infect Immun; 1996 Apr; 64(4):1357-68. PubMed ID: 8606101 [TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide O antigen status of Yersinia enterocolitica O:8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors. Bengoechea JA; Najdenski H; Skurnik M Mol Microbiol; 2004 Apr; 52(2):451-69. PubMed ID: 15066033 [TBL] [Abstract][Full Text] [Related]
8. In vivo-induced InvA-like autotransporters Ifp and InvC of Yersinia pseudotuberculosis promote interactions with intestinal epithelial cells and contribute to virulence. Pisano F; Kochut A; Uliczka F; Geyer R; Stolz T; Thiermann T; Rohde M; Dersch P Infect Immun; 2012 Mar; 80(3):1050-64. PubMed ID: 22158741 [TBL] [Abstract][Full Text] [Related]
9. Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense. Thorslund SE; Ermert D; Fahlgren A; Erttmann SF; Nilsson K; Hosseinzadeh A; Urban CF; Fällman M Infect Immun; 2013 Jan; 81(1):11-22. PubMed ID: 23090955 [TBL] [Abstract][Full Text] [Related]
10. Yersinia pseudotuberculosis YopE prevents uptake by M cells and instigates M cell extrusion in human ileal enteroid-derived monolayers. Fasciano AC; Dasanayake GS; Estes MK; Zachos NC; Breault DT; Isberg RR; Tan S; Mecsas J Gut Microbes; 2021; 13(1):1988390. PubMed ID: 34793276 [TBL] [Abstract][Full Text] [Related]
11. Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. Monack DM; Mecsas J; Bouley D; Falkow S J Exp Med; 1998 Dec; 188(11):2127-37. PubMed ID: 9841926 [TBL] [Abstract][Full Text] [Related]
12. Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica. Trülzsch K; Roggenkamp A; Aepfelbacher M; Wilharm G; Ruckdeschel K; Heesemann J Int J Med Microbiol; 2003 Jun; 293(2-3):167-77. PubMed ID: 12868653 [TBL] [Abstract][Full Text] [Related]
13. Trimer stability of YadA is critical for virulence of Yersinia enterocolitica. Schütz M; Weiss EM; Schindler M; Hallström T; Zipfel PF; Linke D; Autenrieth IB Infect Immun; 2010 Jun; 78(6):2677-90. PubMed ID: 20308293 [TBL] [Abstract][Full Text] [Related]
14. In vivo analysis of Yersinia enterocolitica infection using luxCDABE. Trcek J; Berschl K; Trülzsch K FEMS Microbiol Lett; 2010 Jun; 307(2):201-6. PubMed ID: 20636977 [TBL] [Abstract][Full Text] [Related]
15. Yersinia enterocolitica invasin-dependent and invasin-independent mechanisms of systemic dissemination. Handley SA; Newberry RD; Miller VL Infect Immun; 2005 Dec; 73(12):8453-5. PubMed ID: 16299350 [TBL] [Abstract][Full Text] [Related]
16. The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis. Schiano CA; Bellows LE; Lathem WW Infect Immun; 2010 May; 78(5):2034-44. PubMed ID: 20231416 [TBL] [Abstract][Full Text] [Related]
17. Role of the Yersinia pseudotuberculosis Virulence Plasmid in Pathogen-Phagocyte Interactions in Mesenteric Lymph Nodes. Bliska JB; Brodsky IE; Mecsas J EcoSal Plus; 2021 Dec; 9(2):eESP00142021. PubMed ID: 34910573 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis. Dessein R; Gironella M; Vignal C; Peyrin-Biroulet L; Sokol H; Secher T; Lacas-Gervais S; Gratadoux JJ; Lafont F; Dagorn JC; Ryffel B; Akira S; Langella P; Nùñez G; Sirard JC; Iovanna J; Simonet M; Chamaillard M Gut; 2009 Jun; 58(6):771-6. PubMed ID: 19174417 [TBL] [Abstract][Full Text] [Related]
19. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence. Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271 [TBL] [Abstract][Full Text] [Related]